MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Phase 1
Terminated
Conditions
Coronary Artery Disease
Coronary Artery Disease (CAD)
Heart Disease
Ischemic Heart Disease
First Posted Date
2012-03-19
Last Posted Date
2018-07-05
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
24
Registration Number
NCT01557543
Locations
🇺🇸

Suburban Hospital, Bethesda, Maryland, United States

🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Hemoglobin and Iron Recovery Study

Phase 2
Completed
Conditions
Recovery of Hemoglobin and Iron Stores After Blood Donation
Interventions
Dietary Supplement: ferrous gluconate
First Posted Date
2012-03-15
Last Posted Date
2014-01-23
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
215
Registration Number
NCT01555060
Locations
🇺🇸

Blood Centers of the Pacific, San Francisco, California, United States

🇺🇸

American Red Cross, Connecticut Region, Farmington, Connecticut, United States

🇺🇸

Institute for Transfusion Medicine, PIttsburg, Pennsylvania, United States

and more 1 locations

Carbon Monoxide Levels and Sickle Cell Disease Severity

Completed
Conditions
Sickle Cell Anemia
Sickle Cell Disease
Anemia, Sickle Cell
First Posted Date
2012-03-08
Last Posted Date
2019-04-05
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
106
Registration Number
NCT01547793
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Mutations Associated With Parkinson s Disease

Terminated
Conditions
Parkinson's Disease
First Posted Date
2012-03-08
Last Posted Date
2018-08-29
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
42
Registration Number
NCT01547832
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Improving Blood Stem Cell Collection and Transplant Procedures

Phase 1
Completed
Conditions
Chronic Myelogenous Leukemia
Myelodysplastic Syndrome (MDS)
CLL (Chronic Lymphocytic Leukemia)
Acute Lymphoblastic Leukemia
CML (Chronic Myelogenous Leukemia
Interventions
Procedure: Stem Cell Transplantation
First Posted Date
2012-01-25
Last Posted Date
2018-07-05
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
43
Registration Number
NCT01517035
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Simplified Cardiovascular Management Study

Not Applicable
Completed
Conditions
Cardiovascular Disease
Interventions
Other: Simplified cardiovascular disease management
First Posted Date
2012-01-04
Last Posted Date
2017-05-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
2086
Registration Number
NCT01503814
Locations
🇨🇳

Linzhou, Lhasa, Tibet, China

🇨🇳

Gongbujiangda, Linzhi, Tibet, China

🇮🇳

Faridabad, Haryana, India

PCI-32765 for Special Cases of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Phase 2
Active, not recruiting
Conditions
Leukemia
Leukemia, Lymphocytyc
CLL (Chronic Lymphocytic Leukemia)
SLL (Small Lymphocytic Lymphoma)
Interventions
First Posted Date
2011-12-28
Last Posted Date
2023-04-19
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
86
Registration Number
NCT01500733
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Pericardiocentesis With Magnetic Resonance Imaging

Phase 1
Terminated
Conditions
Cardiac Magnetic Resonance Imaging
First Posted Date
2011-11-24
Last Posted Date
2018-02-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
5
Registration Number
NCT01479569
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Ultra Low Dose Interleukin-2 in Healthy Volunteers

Phase 1
Completed
Conditions
Hematologic Diseases
Interventions
First Posted Date
2011-10-03
Last Posted Date
2020-03-16
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
22
Registration Number
NCT01445561
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Danazol for Genetic Bone Marrow and Lung Disorders

Phase 1
Completed
Conditions
Aplastic Anemia
Interventions
First Posted Date
2011-09-27
Last Posted Date
2018-08-15
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Target Recruit Count
27
Registration Number
NCT01441037
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath